US2008226735A1PendingUtilityA1
Rare earth metal compositions for treating hyperphosphatemia and related methods
Est. expiryMay 24, 2022(expired)· nominal 20-yr term from priority
A61P 7/08A61P 43/00A61P 3/00A61P 3/12A61P 1/00C01F 17/271C01F 17/247C02F 1/281C01P 2004/03B01J 20/0277C01P 2004/61B01J 20/0207C02F 2101/103B01J 20/3078B01J 20/28057C01P 2002/72C01P 2002/60C09C 1/3661C01P 2004/80B01J 20/3234C02F 1/001C01P 2006/90C02F 2101/20B01J 20/0288B01J 20/06C01P 2006/12C02F 2101/105Y10T428/2982C02F 2103/026B01J 20/3236C01P 2006/14A61K 9/0053A61K 9/20A61K 31/28C07F 5/003A61K 9/10A61K 9/08A61K 9/48A61K 33/244A61K 33/24
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the particles and a method of using the particles is disclosed. The particles may be used in the gastrointestinal tract or the bloodstream to remove phosphate or to treat hyperphosphatemia in mammals. The particles may also be used to remove metals from fluids such as water.
Claims
exact text as granted — not AI-modified1 . A method of treating hyperphosphatemia in a mammal, wherein the method comprises administering an effective amount of a composition comprising a rare earth metal compound to the mammal, and wherein the rare earth metal compound exhibits an X-Ray diffraction scan as shown in FIG. 16 , and wherein the rare earth metal compound has a phosphate binding capacity of at least 50 mg PO 4 /g of rare earth metal compound.
2 . The method according to claim 1 , wherein the rare earth metal compound comprises particles, and wherein the particles are between 1 and 1000 μm in size.
3 . The method according to claim 1 , wherein the rare earth metal compound has a phosphate binding capacity of at least 75 mg PO 4 /g of rare earth metal compound.
4 . The method according to claim 1 , wherein the rare earth metal compound has a BET specific surface area of at least about 10 m 2 /g.
5 . The method according to claim 1 , wherein the rare earth metal compound is hydrated.
6 . The method according to claim 2 , wherein the particles comprise individual crystals.
7 . The method according to claim 6 , wherein the rare earth metal compound has a phosphate binding capacity of at least 75 mg PO 4 /g of rare earth metal compound.
8 . The method according to claim 7 , wherein the rare earth metal compound has a BET specific surface area of at least about 10 m 2 /g.
9 . The method according to claim 8 , wherein the rare earth metal compound has a phosphate binding capacity of at least 100 mg PO 4 /g of rare earth metal compound.
10 . The method according to claim 8 , wherein the individual crystals are between 20 nm and 10 μm in size.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.